阿德福韦酯联合胸腺肽α1治疗HBeAg阳性慢性乙型肝炎的近期疗效观察
摘要
目前公认抗病毒治疗是慢性乙型肝炎（CHB）治疗的关键。本研究采用阿德福韦酯联合胸腺肽α1治疗HBeAg阳性慢性乙型肝炎,以探讨其抗病毒疗效。
出处
《肝脏》
2011年第4期323-324,共2页
Chinese Hepatology
参考文献5
-
1茅益民,曾民德.抗乙型病毒性肝炎新药——阿德福韦酯[J].中华肝脏病杂志,2004,12(1):61-63. 被引量：266
-
2中华医学会传染病与,寄生虫病学分会,肝病学分会.病毒性肝炎防治方案[J].中华肝脏病杂志,2000,8(6):324-329. 被引量：14014
-
3聂青和.慢性乙型肝炎抗病毒治疗进展回顾[J].实用肝脏病杂志,2005,8(3):148-150. 被引量：16
-
4段国荣,聂青和,周永兴,王全楚,田长印,刘拉羊,薛红安.胸腺肽α1对慢性乙型肝炎患者免疫系统的影响[J].世界华人消化杂志,2003,11(6):701-704. 被引量：12
-
5周大桥,高辉,彭立生,邱梅,漆艳萍,周师,周静,邹映珍.日达仙为主治疗慢性丙型肝炎30例疗效观察[J].中华实验和临床病毒学杂志,1998,12(1):97-97. 被引量：10
二级参考文献41
-
1Zu Hu Huang1,Hui Zhuang2,Shan Lu3,Ren Hua Guo1,Guo Min Xu2,Jie Cai1,Wan Fu Zhu2 1Department of Infectious Diseases. The First Affiliated Hospital of Nanjing Medical University, Nenjing 210029, Jiangsu Province. China2Faculty of Microbiology, Beijing University, Beijing 100000, China3University of Massachusetts Medical Center.Humoral and cellular immunogenecity of DNA vaccine based on hepatitis B core gene in rhesus monkeys[J].World Journal of Gastroenterology,2001,7(1):102-106. 被引量：19
-
2Lin Zhuang Jing You Bao Zhang Tang Su Ying Ding Kui Hua Yan Dan Peng Yan Mei Zhang Lu Zhang ~1Department of Hepatology,Kunming Third Municipal Peoples Hospital,Kunming 650041,Yunnan Province,China ~2Department of Infectious Diseases,The First Affiliated Hospital of Kunming Medical College,Kunming 650032,Yunnan Province,China.Preliminary results of Thymosin-a1 versus interferon-α treatment in patients with HBeAg negative and serum HBV DNA positive chronic hepatitis B[J].World Journal of Gastroenterology,2001,7(3):407-410. 被引量：23
-
3Fu-Sheng Wang Li-He Xing Ming-Xu Liu Chuan-Lin Zhu Hui-Gang Liu Hui-Fen Wang Zhou-Yun Lei Division of Biological Engineering,~2 Fourth Department of Liver Diseases,Beijing Institute of Infectious Diseases,Beijing Hospital of Infectious Diseases,Beijing 100039,China.Dysfunction of peripheral blood dendritic cells from patients with chronic hepatitis B virus infection[J].World Journal of Gastroenterology,2001,7(4):537-541. 被引量：131
-
4CHEN Kun, HAN Bao Guang, MA Xian Kai, ZHANG He Qiu, MENG Li, WANG Guo Hua, XIA Fang, SONG Xiao Guo and LING Shi Gan.Establishment and preliminery use of hepatitis Bvirus preS1/2 antigen assay[J].World Journal of Gastroenterology,1999,5(6):550-552. 被引量：14
-
5ZENG Xian Jia 1, YANG Gong Huan 2, LIAO Su Su 1, CHEN Ai Ping 2, TAN Jian 2, HUANG Zheng Jing 2 and LI Hui 1.Survey of coverage,strategy and cost of hepatitis B vaccination in rural and urban areas of China[J].World Journal of Gastroenterology,1999,5(4):48-51. 被引量：8
-
6TANG Ren Xian, GAO Feng Guang, ZENG Ling Yu, WANG Ying Wei and WANG Yu Long.Detection of HBV DNA and its existence status in liver tissues and peripheral blood lymphocytes from chronic hepatitis B patients[J].World Journal of Gastroenterology,1999,5(4):87-89. 被引量：27
-
7Bendele RA,Richardson FC.Adefovir nephrotoxicity and mitochondrial DNA depletion[].Human Pathology.2002 被引量：1
-
8Ho ES,Lin DC,Mendel DB,et al.Cytotoxicity of antiviral nucle-otides adefovir and cidofovir is induced by the expression of human renal organic anion transporter 1[].Journal of the American Society of Nephrology.2000 被引量：1
-
9Cullen JM,Li DH,Brown C,et al.Antiviral efficacy and pharmaco- kinetics of oral adefovir dipivoxil in chronically woodchuck hepatitis virus-infected woodchucks[].Antimicrobial Agents and Chemotherapy.2001 被引量：1
-
10Delaugerre C,Marcelin AG,Thibault V,Peytavin G,et al.Human immunodeficiency virus(HIV) Type 1 reverse transcriptase resistance mutation in hepatitis B virus(HBV)-HIV-coinfected patients treated for HBV chronic infection once daily with 10 milligrams of adefovir dipivoxil combined with lamivudine[].Antimicrobial Agents and Chemotherapy.2002 被引量：1
共引文献14218
-
1刘洋.复方木鸡颗粒联合替诺福韦治疗代偿期乙型肝炎肝硬化患者的临床研究[J].慢性病学杂志,2019,0(12):1853-1854.
-
2李钊,黄宛香,李繁.乙型肝炎病毒感染肝硬化AST/ALT和LSM值与Child-Pugh分级及临床分期关系[J].热带医学杂志,2023,23(11):1593-1596. 被引量：1
-
3曾远松,黄柳春.茵郁芪灵汤联合恩替卡韦治疗慢性乙型肝炎的疗效观察[J].内蒙古中医药,2021,40(5):13-14. 被引量：2
-
4宫笑一,刘守华.代偿期乙肝肝硬化患者服用恩替卡韦对血清甲状腺激素水平的影响[J].中国农村卫生,2018,0(16):78-78.
-
5王雪艳,张旭东.甘草酸二铵对乙肝肝硬化患者TBIL、CⅣ及炎性因子的影响分析[J].医药论坛杂志,2021,42(16):7-10.
-
6欧阳福生.老年病毒性肝炎267例临床报告[J].山东大学学报（医学版）,2014,52(S01):83-84.
-
7吴荣荣,赵庆国,秦立,刘峰群,韩晋.3种方法测定阿德福韦酯片晶型[J].医药导报,2015,34(S01):99-100. 被引量：2
-
8潘晓华.阿德福韦酯联合拉米夫定治疗乙肝肝硬化患者80例8年的临床报道[J].世界最新医学信息文摘,2020(48):108-109.
-
9付振双.恩替卡韦治疗失代偿期慢性乙型病毒性肝炎肝硬化的临床研究[J].世界最新医学信息文摘,2020(2):150-150. 被引量：1
-
10陈新梅,陈昆迪.重型肝病转归与季节关系的探讨[J].医学信息,2018,31(A02):62-63.
-
1路洪艳.阿德福韦酯联合免疫调节剂治疗慢性乙型肝炎的临床效果分析[J].中国医药指南,2014,12(27):139-140.
-
2翁浩波.阿德福韦酯联合胸腺肽α_1治疗慢性乙型病毒性肝炎效果观察[J].中国乡村医药,2012,19(2):8-9. 被引量：3
-
3朱艾征.阿德福韦酯联合胸腺肽α_1及苦参素治疗慢性乙型肝炎50例临床分析[J].河南科技大学学报（医学版）,2010,28(1):38-39.
-
4杨玉贵.阿德福韦酯联合胸腺肽α1治疗慢性乙型病毒性肝炎效果观察[J].中国实用医药,2013,8(11):142-143. 被引量：2
-
5朱华波.阿德福韦酯联合胸腺肽α1治疗YMDD变异慢性乙型肝炎的疗效观察[J].医学临床研究,2011,28(3):549-550. 被引量：1
-
6谷军生,姚丽娜,江河清.阿德福韦酯联合胸腺肽α1治疗慢性乙型肝炎[J].中国实用医刊,2009,36(19):39-40.
-
7吴建明,谢新生,何剑琴.阿德福韦酯联合胸腺肽α1治疗高病毒载量慢性乙型肝炎110例临床分析[J].中华临床感染病杂志,2012,5(6):355-356. 被引量：3
-
8赵文莉,杨忠民.胸腺肽α_1联合阿德福韦酯治疗慢性乙型肝炎疗效观察[J].现代中西医结合杂志,2014,23(1):82-83. 被引量：2
-
9董九炎.阿德福韦酯联合胸腺肽α1对拉米夫定无应答HBeAg阴性慢性乙型肝炎的治疗效果分析[J].河南医学研究,2015,24(9):51-52. 被引量：1
-
10汤茂刚.阿德福韦酯联合胸腺肽α1治疗慢性乙型肝炎的疗效观察[J].实用肝脏病杂志,2008,11(3):185-186. 被引量：6
